Published by Josh White on 26th September 2022
(Sharecast News) - Molecular diagnostics technology company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has transferred the evaluation of its 'MT-RNR1' test to a new 'early value assessment programme'.
URL: http://www.digitallook.com/dl/news/story/32987874/...